Nurulimab | m-entrepreneurship.com

Product Name :
Nurulimab

Search keywords :
Nurulimab

drugId :
null

Target Vo:
Cytotoxic T-Lymphocyte-Associated Antigen 4

Target Vo Short Name :
CTLA4

Moa_Name:
Cytotoxic T-Lymphocyte-Associated Antigen 4 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Biocad

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Melanoma

Termination Status :
Phase 1 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FGFR3 Rabbit mAb Autophagy
Belimumab supplier
Ki-67 Antibody: Ki-67 Antibody is an unconjugated, approximately 358 kDa, rabbit-derived, anti-Ki-67 polyclonal antibody. Ki-67 Antibody can be used for: WB, ELISA, IHC-P, IHC-F, Flow-Cyt, ICC, IF expriments in human, mouse, background without labeling.

Author: Betaine hydrochloride

Related Posts